Future care for long‑term cancer survivors:: towards a new model

• M. Provencio ^[1] ; N. Romero ^[6] ; J. Tabernero ^[7] ; R. Vera ^[8] ; D. V. Baz ^[2] ; A. Arraiza ^[9] ; C. Camps ^[10] ; E. Felip ^[11] ; P. Garrido ^[3] ; B. Gaspar ^[12] ; M. Llombart ^[13] ; A. López ^[14] ; I. Magallón ^[15] ; V. M. Ibáñez ^[16] ; J. M. Olmos ^[17] ; C. Mur ^[18] ; A. Navarro Ruiz ^[19] ; A. Pastor ^[20] ; M. Peiró ^[4] ; J. Polo ^[21] ; Á. Rodríguez Lescure ^[5]
  1. [1] Hospital Universitario Puerta de Hierro

     Hospital Universitario Puerta de Hierro

     Madrid, España

     
  2. [2] Hospital Universitario Virgen Macarena

     Hospital Universitario Virgen Macarena

     Sevilla, España

     
  3. [3] Hospital Ramón y Cajal

     Hospital Ramón y Cajal

     Madrid, España

     
  4. [4] Universitat Ramon Llull

     Universitat Ramon Llull

     Barcelona, España

     
  5. [5] Hospital General Universitario de Elche

     Hospital General Universitario de Elche

     Elche, España

     
  6. [6] Cardiology and Cardiac Surgery Clinical Management Unit, Hospital Virgen del Rocio, Sevilla, Spain
  7. [7] Medical Oncology Department, Hospital Universitario Vall d’HebronVHIOEuropean Society for Medical Oncology (ESMO), Barcelona, Spain
  8. [8] Medical Oncology Department, Complejo Hospitalario de NavarraServicio Navarro de la SaludSpanish Society of Medical Oncology (SEOM), Navarra, Spain
  9. [9] Health Programmes, Health Care, Osakidetza, País Vasco, Spain
  10. [10] Medical Oncology Department, Hospital General Universitario de ValenciaUniversidad de Valencia CIBERONCECO Foundation, Valencia, Spain
  11. [11] Institut d’Oncologia, Vall d’Hebron University Hospital, Spanish Society of Medical Oncology (SEOM), Barcelona, Spain
  12. [12] Spanish Association of Lung Cancer Patients (AEACaP), Valencia, Spain
  13. [13] alencia Oncology Institute Foundation, Valencia, Spain
  14. [14] Pharmacy, Navarra Health Service—Osasunbidea, Navarra, Spain
  15. [15] Medical Oncology Department, Hospital Universitario Vall d’Hebron, Spanish Oncology Nursing Society (SEEO), Barcelona, Spain
  16. [16] Professional Organization of the Ministry of Health, Madrid, Spain
  17. [17] Senate Health Committee, Andalusian School of Public Health, Granada, Spain
  18. [18] línicas CAT Barcelona, Spanish Society of Health Directors (SEDISA), Barcelona, Spain
  19. [19] Hospital Pharmacy ServiceHospital General Universitario de ElcheSpanish Society of Hospital Pharmacy, Alicante, Spain
  20. [20] Spanish Society of Family and Community Medicine (SEMFyC), Madrid, Spain
  21. [21] Centro de Salud Casar de Cáceres, Spanish Society of Primary Care Physicians (SEMERGEN), Cáceres, Spain

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 24, Nº. 2, 2022, págs. 350-362
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)
• Resumen

  • Purpose The increase in the prevalence "long-term cancer survivor” (LCS) patients is expected to increase the cost of LCS care. The aim of this study was to obtain information that would allow to optimise the current model of health management in Spain to adapt it to one of efficient LCS patient care.

    Methods This qualitative study was carried out using Delphi methodology. An advisory committee defined the criteria for participation, select the panel of experts, prepare the questionnaire, interpret the results and draft the final report.

    Results 232 people took part in the study (48 oncologists). Absolute consensus was reached in three of the proposed sec- tions: oncological epidemiology, training of health professionals and ICT functions.

    Conclusion The role of primary care in the clinical management of LCS patients needs to be upgraded, coordination with the oncologist and hospital care is essential. The funding model needs to be adapted to determine the funding conditions for new drugs and technologies.